1 Labovitz E, levinon ME, kaye D. Single dose daily gentamicin therapy in urinary tract infection. Antimicrob Agents Chemother, 1974, 6:465 2 Sahm DF, Washington I J A. Antibacterial suscep-tibility tcsts: dilutron methods. Manual of Clinical Micro biology. 5th ed, 991:1105 3 Resott DL. Nix DE, HoldenP, et al. Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli. Antimicrob A-gents Chemother, 1988;32:450 4 Vogelman BS, Craig WA. Postantibiotic effects. J Antimicrob Chemother, 1985; 15(suppl A):37 5 Michael Spirey. The postantibiotic effect. Clin Pharm, 1992, 11: 865 6 Craig WA,Vogelman B. The postantibiotic efect. Ann Intern Med, 1987, 106: 900 7 Bundtzen RW, Gerber AU, Cohn DL, et al. Postan-tibiotie suppression of bacterial growth. Rev Infect Dis, 1981,3:28 8 William A,Craig WA. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J An-timicro chemother, 1993, 31(suppl. D):149 9 Roosendoal R,Bokker-Wondenberg LAJM,Van den Berghevan Raffe M, et al. Continuous versus inter-mittent administration of ceftazidime in experimental. Klebsiella pneumoniae pneumonia in normal and lukopenic rats. Antimicrob Agents Chemother, 1986, 30:403 10 Winstanldy TG, Hastings. JG J. Penicilin amino-glycoside synergg and post-antibiotic effect for entero-cocci. Antimicrob chemother, 1993, 32(2):215 |